<!DOCTYPE html>

<html lang="en" data-content_root="./">
  <head>
    <meta charset="utf-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1.0" /><meta name="viewport" content="width=device-width, initial-scale=1" />

    <title>腸泌素Glucagon-like peptide-1(GLP-1) &#8212; 林智敏醫師  documentation</title>
    <link rel="stylesheet" type="text/css" href="_static/pygments.css?v=d1102ebc" />
    <link rel="stylesheet" type="text/css" href="_static/basic.css?v=686e5160" />
    <link rel="stylesheet" type="text/css" href="_static/alabaster.css?v=27fed22d" />
    <script src="_static/documentation_options.js?v=5929fcd5"></script>
    <script src="_static/doctools.js?v=9bcbadda"></script>
    <script src="_static/sphinx_highlight.js?v=dc90522c"></script>
    <link rel="index" title="Index" href="genindex.html" />
    <link rel="search" title="Search" href="search.html" />
    <link rel="next" title="免責聲明" href="law.html" />
    <link rel="prev" title="得舒飲食(DASH)" href="DASH.html" />
   
  <link rel="stylesheet" href="_static/custom.css" type="text/css" />
  

  
  

  </head><body>
  

    <div class="document">
      <div class="documentwrapper">
        <div class="bodywrapper">
          

          <div class="body" role="main">
            
  <section id="glucagon-like-peptide-1-glp-1">
<h1>腸泌素Glucagon-like peptide-1(GLP-1)<a class="headerlink" href="#glucagon-like-peptide-1-glp-1" title="Link to this heading">¶</a></h1>
<section id="semaglutide">
<span id="id1"></span><h2>司美格魯泰(Semaglutide)是什麼藥物？<a class="headerlink" href="#semaglutide" title="Link to this heading">¶</a></h2>
<ul class="simple">
<li><p>Glucagon-like peptide-1(GLP-1)糖尿病藥物</p></li>
<li><p>具有體重減輕作用。FDA核可用於減重，但未經衛福部核可應用於減重。</p></li>
<li><p>非糖尿病者是否能減重尚未廣泛接受。</p></li>
</ul>
</section>
<section id="glp1">
<h2>GLP1常見不適<a class="headerlink" href="#glp1" title="Link to this heading">¶</a></h2>
<ul class="simple">
<li><p>噁心，腹瀉</p></li>
<li><p>情緒異常</p></li>
<li><p>心跳快</p></li>
<li><p>視網膜病變併發症（玻璃體出血、失明或需要玻璃體內藥物或光凝固治療的病症）的發生率顯著較高（風險比，1.76)(<a class="reference external" href="https://pubmed.ncbi.nlm.nih.gov/27633186/">https://pubmed.ncbi.nlm.nih.gov/27633186/</a>)</p></li>
<li><p>停藥後體重反彈。</p></li>
</ul>
</section>
<section id="id2">
<h2>GLP1可能的副作用？(以下列出者尚未有廣泛證據證實，仍需進一步研究)<a class="headerlink" href="#id2" title="Link to this heading">¶</a></h2>
<ul class="simple">
<li><p>急性胰臟炎。(案例：<a class="reference external" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10506915/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10506915/</a>)</p></li>
<li><p>膽囊結石。</p></li>
<li><p>肌肉流失，然而減重對於整體健康仍可能有益處。(<a class="reference external" href="https://www.investors.com/news/technology/weight-loss-drugs-how-outliers-like-biohaven-regeneron-are-trying-to-squeeze-into-the-obesity-space/?src=A00220&amp;yptr=yahoo">https://www.investors.com/news/technology/weight-loss-drugs-how-outliers-like-biohaven-regeneron-are-trying-to-squeeze-into-the-obesity-space/?src=A00220&amp;yptr=yahoo</a>)</p></li>
<li><p>口服semaglutide減重效果尚未被廣泛接受，仍有其他研究正在進行。(<a class="reference external" href="http://www.genetinfo.com/international-news/item/76574.html">http://www.genetinfo.com/international-news/item/76574.html</a>)</p></li>
<li><p>歐盟藥品監管機構沒有發現semaglutide與自殺意念有相關。(<a class="reference external" href="https://medriva.com/weight-management/eu-regulators-see-no-link-between-weight-loss-drugs-and-suicidal-thoughts-4480761">https://medriva.com/weight-management/eu-regulators-see-no-link-between-weight-loss-drugs-and-suicidal-thoughts-4480761</a>)</p></li>
</ul>
</section>
<section id="saxenda">
<h2>膳纖達(Saxenda)是什麼藥物？<a class="headerlink" href="#saxenda" title="Link to this heading">¶</a></h2>
<ul class="simple">
<li><p>GLP-1 糖尿病藥物</p></li>
<li><p>具有體重減輕作用。衛福部核可用於減重。</p></li>
<li><p>非糖尿病者是否能減重尚未廣泛接受。</p></li>
<li><p>副作用與semaglutide類似。</p></li>
</ul>
</section>
<section id="id3">
<h2>其他正在研究之中的相關藥物有哪些？<a class="headerlink" href="#id3" title="Link to this heading">¶</a></h2>
<p>西方肥胖率高，減重市場廣大，GLP1具備明顯的減重效果，日漸受到藥廠重視，成為資本市場炒作熱點。
除了諾和諾德的semaglutide，其他另有禮來(NYSE: LLY)的Mounjaro(Tirzepatide)。
另外，安進(Amgen Inc. (AMGN))等藥廠正在研究AMG-133(Maritide)藥物的臨床效果，其除了GLP1效果，
還有另一種Gastric inhibitory polypeptide receptor(GIP-R)靶點，研究人員希望能達成停藥之後更持久的減重效果。</p>
</section>
</section>


          </div>
          
        </div>
      </div>
      <div class="sphinxsidebar" role="navigation" aria-label="Main">
        <div class="sphinxsidebarwrapper">
<h1 class="logo"><a href="index.html">林智敏醫師</a></h1>









<search id="searchbox" style="display: none" role="search">
    <div class="searchformwrapper">
    <form class="search" action="search.html" method="get">
      <input type="text" name="q" aria-labelledby="searchlabel" autocomplete="off" autocorrect="off" autocapitalize="off" spellcheck="false" placeholder="Search"/>
      <input type="submit" value="Go" />
    </form>
    </div>
</search>
<script>document.getElementById('searchbox').style.display = "block"</script><h3>Navigation</h3>
<ul class="current">
<li class="toctree-l1"><a class="reference internal" href="index.html">Home</a></li>
<li class="toctree-l1"><a class="reference internal" href="clinical_service.html">林智敏醫學博士</a></li>
<li class="toctree-l1"><a class="reference internal" href="biography.html">學術活動</a></li>
<li class="toctree-l1 current"><a class="reference internal" href="health_information.html">衛教資訊</a><ul class="current">
<li class="toctree-l2"><a class="reference internal" href="HTN.html">高血壓</a></li>
<li class="toctree-l2"><a class="reference internal" href="dislipidemia.html">血脂肪過高</a></li>
<li class="toctree-l2"><a class="reference internal" href="weight_management.html">體重管理</a></li>
<li class="toctree-l2"><a class="reference internal" href="fattyliver.html">脂肪肝</a></li>
<li class="toctree-l2"><a class="reference internal" href="gout.html">尿酸過高</a></li>
<li class="toctree-l2"><a class="reference internal" href="NSAID.html">非類固醇抗發炎藥(NSAID)</a></li>
<li class="toctree-l2"><a class="reference internal" href="DASH.html">得舒飲食(DASH)</a></li>
<li class="toctree-l2 current"><a class="current reference internal" href="#">腸泌素Glucagon-like peptide-1(GLP-1)</a><ul>
<li class="toctree-l3"><a class="reference internal" href="#semaglutide">司美格魯泰(Semaglutide)是什麼藥物？</a></li>
<li class="toctree-l3"><a class="reference internal" href="#glp1">GLP1常見不適</a></li>
<li class="toctree-l3"><a class="reference internal" href="#id2">GLP1可能的副作用？(以下列出者尚未有廣泛證據證實，仍需進一步研究)</a></li>
<li class="toctree-l3"><a class="reference internal" href="#saxenda">膳纖達(Saxenda)是什麼藥物？</a></li>
<li class="toctree-l3"><a class="reference internal" href="#id3">其他正在研究之中的相關藥物有哪些？</a></li>
</ul>
</li>
<li class="toctree-l2"><a class="reference internal" href="law.html">免責聲明</a></li>
</ul>
</li>
</ul>

<div class="relations">
<h3>Related Topics</h3>
<ul>
  <li><a href="index.html">Documentation overview</a><ul>
  <li><a href="health_information.html">衛教資訊</a><ul>
      <li>Previous: <a href="DASH.html" title="previous chapter">得舒飲食(DASH)</a></li>
      <li>Next: <a href="law.html" title="next chapter">免責聲明</a></li>
  </ul></li>
  </ul></li>
</ul>
</div>








        </div>
      </div>
      <div class="clearer"></div>
    </div>
    <div class="footer">
      &#169;2024, JML team.
      
      |
      Powered by <a href="https://www.sphinx-doc.org/">Sphinx 8.1.3</a>
      &amp; <a href="https://alabaster.readthedocs.io">Alabaster 1.0.0</a>
      
      |
      <a href="_sources/GLP1.rst.txt"
          rel="nofollow">Page source</a>
    </div>

    

    
  </body>
</html>